First Eagle Investment Management

First Eagle Investment Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

First Eagle Investment Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-219,420	Closed	-$507K	–	190
2018 Q2	$507K	Hold	219,420	–	–	﹤0.01%	162
2018 Q1	$698K	Hold	219,420	–	–	﹤0.01%	162
2017 Q4	$900K	Hold	219,420	–	–	﹤0.01%	231
2017 Q3	$992K	Hold	219,420	–	–	﹤0.01%	245
2017 Q2	$731K	Buy	219,420 +60,000	+38%	+$249K	﹤0.01%	228
2017 Q1	$1.47M	Sell	159,420 -70,980	-31%	-$623K	﹤0.01%	209
2016 Q4	$1.78M	Hold	230,400	–	–	﹤0.01%	202
2016 Q3	$2.63M	Buy	230,400 +153,030	+198%	+$1.78M	0.01%	209
2016 Q2	$952K	Sell	77,370 -107,060	-58%	-$1.3M	﹤0.01%	252
2016 Q1	$1.86M	Buy	+184,430	New	+$2.17M	﹤0.01%	210

Other funds holding OMED

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return